Brukinsa® (zanubrutinib)
for Leukemia

Brukinsa (zanubrutinib) is a Bruton's tyrosine kinase (BTK) inhibitor used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, marginal zone lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and follicular lymphoma. It blocks BTK signaling, reducing cancerous white blood cell growth and spread.

Heart
Other top medicines used to treat Leukemia